NSC |
Compound |
Enrichment |
Correlation |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0430505868034761 |
0.28725933 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0430505868034761 |
0.34500547 |
NSC 733504 |
Everolimus |
0.0430505868034761 |
-0.28720629 |
NSC 743528 |
Null |
0.0430505868034761 |
0.26365204 |
NSC 743530 |
Null |
0.0430505868034761 |
0.43809154 |
NSC 743876 |
Null |
0.0430505868034761 |
0.23779717 |
NSC 754245 |
5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione |
0.0430505868034761 |
0.18512952 |
NSC 756053 |
Null |
0.0430505868034761 |
-0.38699476 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0430505868034761 |
0.2068718 |
NSC 121713 |
Null |
0.0430505868034764 |
0.47419644 |